P506 Understanding Gender Differences in IBS: The Role of Stress From the Social Environment
Author insight from Jeffrey Lackner, PsyD, University at Buffalo, SUNY, Buffalo, NY
What’s new here and important for clinicians?
- IBS is a painful, disabling GI disorder that affects some 40 million Americans and is one of the most common disorders seen by gastroenterologists and primary care physicians.
- While women are twice as likely to have IBS, it still affects 10 million males about whom little is known.
- Research exploring the different ways that males and females experience IBS can lead to more targeted and effective treatments for all sufferers but this has been difficult because studies have largely excluded males.
- Data upon which this study is based comes from a landmark NIH-funded study lead by the University at Buffalo that is one of the few to systematically assess both male and female IBS patients with more severe GI symptoms.
- While males did not differ from females in terms of digestive health and well-being, males reported more interpersonal difficulties, specifically receiving less support from others and more interpersonal problems. Male patients also described themselves as having limited affection and somewhat detached from others and a tendency to dominate interpersonal .relationships.
- Gastroenterologists, but not patients, associated interpersonal difficulties with more severe IBS symptoms.
What do patients need to know?
- The ways that patients interact with others may impact their physicians’ understanding of the severity of IBS symptoms and the quality of the physician-patient relationship.
- Patients who have a domineering and distant interpersonal style may need to work more closely with their gastroenterologists to arrive at a shared understanding of the nature of GI symptoms, their severity and their impact so that they get the most out of treatments and the doctor-patient relationship.
Jeffrey Lackner, PsyD, University at Buffalo, SUNY, Buffalo, NY
Oral 12 Analysis of Exhaled Volatile Organic Compounds Reveals New Biomarkers for Irritable Bowel Syndrome
P1719 Regional Variation of Care for Irritable Bowel Syndrome in the United States
P1718 Age-Related Health Care Disparities in Patients With Irritable Bowel Syndrome: Findings From a Sample of Commercially Insured Patients
P1110 Cognitive Behavioral Self-Help for Irritable Bowel Syndrome
P1117 What Strategies Do Patients With Irritable Bowel Syndrome Continue to Use Following a 9-Week Comprehensive Self-Management Program?
P1111 Two Years on Linaclotide: Tolerability and Treatment Satisfaction in IBS-C Patients With and Without Diarrhea
Media Interview Requests:
To arrange an interview with any ACG experts or abstract authors please contact Jacqueline Gaulin of ACG via email firstname.lastname@example.org or by phone at 301-263-9000.